Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 650x80px
Collaboration › Details

United States (govt)–Cobo Technologies: genome editing, 201904– collab Cobo beomes member of NIST Genome Editing Consortium

 

Period Period 2019-04-15
Region Region United States (USA)
Organisations Partner, 1st NIST Genome Editing Consortium
  Group United States (govt)
  Partner, 2nd Cobo Technologies ApS
Product Product  CRISPR INDEL Profiling Platform (CIPP™)
Person Person Herlevsen, Hasse (Cobo Technologies 201904– COO + Co-Owner before Leo Pharma)
     

Cobo Technologies ApS. (4/15/19). "News: Cobo Technologies Member of NIST Genome Editing Consortium, US".

We are excited to announce that we have become member of the NIST - Genome Editing Consortium in US.

Our team will contribute with our broad knowledge about INDEL analysis of CRISPR modified cells using our proprietary INDEL Profiling Platform, CIPP - powered by the IDAA method.

Read also the announcement in the Danish MEDWATCH 2019-04-16

Learn more about the NIST - Genome Editing Consortium below or at the webpage:

"Targeted genome editing, a method used to alter the DNA of living cells at desired locations, is poised to revolutionize science and medicine. To fight diseases, novel genome edited therapeutics, including those for use in regenerative medicine and infectious diseases, are being developed. Many commercial applications including agriculture and chemical production, are also leveraging this technology. Whether genome editing will be used in healthcare, agriculture or basic research, robust quantitative measurements are needed to enable high confidence characterization of DNA alterations. NIST has brought together experts across the genome editing field including stakeholders in industry, academia and government to assess their measurement needs. These discussions have identified common pre-competitive measurements and standards needed to establish greater confidence in the characterization of genome editing outputs. The NIST- Genome Editing Consortium has been established to address these needs"

Goals:

Evaluate genome editing assay pipelines
Develop benchmark materials
Generate benchmark data
Develop suggested minimal information reporting for public studies
Generate a common lexicon for genome editing studies

https://medwatch.dk/secure/Top_picks_in_english/article11323389.ece

https://www.nist.gov/programs-projects/nist-genome-editing-consortium

   
Record changed: 2019-07-06

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for United States (govt)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px




» top